Physician

Christopher John Seebruck, M.D.

According to 2025 Medicare claims, Christopher Seebruck, M.D. (NPI: 1598999542) practices ophthalmology in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Fayette, PA. This provider's primary affiliated billing organization is LEHIGH VALLEY EYE CENTER, P.C. (NPI: 1356330369; TIN: 232785660) and primary practice location at 15401-8002.

Seebruck's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 689 traditional Medicare patients, billed 38,269 HCPCS/CPT codes, and received $3,467,150 in Medicare payments. The top billing code was 92235 (Exam of retinal blood vessels using a special camera after injection of a dye). Part D data shows 629 prescription claims across 204 beneficiaries totaling $80,368 in drug costs, led by Cyclosporine (Cyclosporine). Open Payments data shows 9 records totaling $248. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,896,805 to $3,467,150. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $81,673 and ending at $80,368. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	633	10,289	$1,896,805
2016	619	11,599	$2,117,837
2017	569	8,938	$1,761,921
2018	587	8,876	$1,665,316
2019	657	11,441	$2,316,560
2020	627	8,419	$1,650,767
2021	733	12,659	$2,712,383
2022	790	15,138	$3,025,187
2023	750	19,791	$3,013,492
2024	689	38,269	$3,467,150

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	122	387	$81,673
2016	238	856	$129,294
2017	247	888	$85,446
2018	221	792	$88,157
2019	192	624	$66,016
2020	211	728	$90,096
2021	224	900	$120,032
2022	223	768	$107,907
2023	244	633	$93,078
2024	204	629	$80,368

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92235	Exam of retinal blood vessels using a special camera after injection of a dye	380	1,136	$109
67028	Injection of drug into eye	308	2,385	$93
92014	Established patient complete exam of visual system	621	1,339	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	237	428	$68
92134	Imaging of retina	670	2,793	$28

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cyclosporine	Cyclosporine	26	1,635	$16,916
Restasis	Cyclosporine	16	660	$13,469
Lumigan	Bimatoprost	11	635	$6,248
Rhopressa	Netarsudil Mesylate	12	638	$5,053
Prednisolone Acetate	Prednisolone Acetate	147	4,142	$4,311

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$248	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher John Seebruck, M.D.?

Tedicare shows public-source Medicare data for Christopher John Seebruck, M.D. (NPI 1598999542), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher John Seebruck, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher John Seebruck, M.D.?

Christopher John Seebruck, M.D. is linked to LEHIGH VALLEY EYE CENTER, P.C. (billing NPI 1356330369) in the available physician profile data.

Does Christopher John Seebruck, M.D. have Open Payments data?

Christopher John Seebruck, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.